Tue, Nov 26, 2013 -- 9:00 AM
FDA Orders 23andMe to Halt SalesDownload audio (MP3)
The Food and Drug Administration has ordered Silicon Valley gene-testing service 23andMe to halt all sales and marketing of its gene testing kits. 23andMe led the way in the personal-genomics revolution after it was declared Time Magazine's 2008 invention of the year, but regulators have concerns that inaccurate results from the direct-to-consumer tests, or results that are not adequately understood by patients, could lead to dangerous decisions. Forum discusses the FDA's order and the future of personal gene tests.
Host: Dave Iverson
- Hank Greely, director of the Center for Law and the Biosciences and law professor at Stanford University
- Christina Farr, health reporter for Venture Beat
- Nita Farahany, professor of genome sciences and policy and law professor at Duke University; also a member of the Presidential Commission for the Study of Bioethical Issues
- Courtney Lias, director of chemistry and toxicology devices at the Center for Devices and Radiological Health at the Food and Drug Administration